手机版 客户端

基于解毒通络探讨柴胡多糖阻断HMGB1-TLR2/4信号通路防治糖尿病肾病

基于解毒通络探讨柴胡多糖阻断HMGB1-TLR2/4信号通路防治糖尿病肾病
  • 导航:首页 > 科学基金
  • 批准号:81673658
  • 批准年度: 2016年
  • 学科分类:中药内分泌及代谢药理(H2811) |
  • 项目负责人:翁鸿博
  • 负责人职称:讲师
  • 依托单位:复旦大学
  • 资助金额:57万元
  • 项目类别:面上项目
  • 研究期限:2017年01月01日 至 2020年12月31日
  • 中文关键词: 多糖;阻断;HMGB1-TLR2/4;防治;糖尿病肾病
  • 英文关键词:diabetes nephyropathy;Bupleurm polysaccharides;HMGB1-TLR2/4 ;inflammation;Nuclear factor kB (NF-kB)

项目摘要

中文摘要

糖尿病肾病(DN)是糖尿病的严重并发症,也是终末期肾病的主要原因,目前尚无有效药物。TLR2/4识别HMGB1而启动炎症反应与DN发生发展密切相关。解毒通络抑制炎症是防治DN的重要策略。前期研究发现,柴胡多糖抑制TLR4通路而降低炎症水平;改善STZ诱导的DN小鼠肾损伤,降低HMGB1表达。由此推测:柴胡多糖通过阻断HMGB1-TLR2/4信号通路治疗DN。本课题拟采用自发和诱导两种DN模型进一步观察柴胡多糖的药效及机制,在分子和细胞水平上,重点观察柴胡多糖对HMGB1表达、分泌及活性的影响,探讨HMGB1作为治疗DN新靶点的可能性;观察柴胡多糖对NF-κB入核的影响,判断其是否独立于对TLR2/4的作用;通过对TLR2 siRNA沉默和对TLR4作用的拮抗,观察柴胡多糖对TLR2和TLR4作用的差异。明确柴胡多糖治疗DN的作用机制,能够为在中药中挖掘DN治疗药物提供新的思路和研究方向。

英文摘要

Diabetic Nephropathy(DN), a type of capillary vessel syndrome, is one of the most common and severe chronic complications of diabetes mellitus. Diabetic nephropathy is the leading cause of end-stage renal disease. There is no effective drug for treating DN. Diabetic nephropathy (DN) is an inflammatory disease. HMGB1 is an endogenous ligand of TLR2/4. HMGB1 mediated TLR2/4 signaling pathway has been confirmed to involve in the pathogenesis of DN. According to integrated traditional Chinese and western medicine theory, JieDuTongLuo and inhibition of inflammation is a new strategy for the treatment of DN. Our previous study found that Bupleurm polysaccharides(BPs)inhibited TLR4 signaling pathway and decreased the level of inflammatory cytokines. BPs improved kidney damage and reduced the expression of HMGB1 in renal tubules in DN mice. We hypothesized that the therapeutic effect of BPs on DN resulted from blocking the HMGB1 mediated TLR2/4 signaling pathway. In this study, both spontaneous and induced DN mice will be used to determine the effect of BPs on DN. We will focus on the effect of BPs on HMGB1 structure, expression, secretion and TLR2/4 binding activity. It is evaluated that HMGB1 might be a new target for DN therapy. To determine whether BPs independent of TLR2/4 signaling pathway exerts its anti-inflammatory activity, the translocation of NF-κB to nuclear is observed. Through siRNA silencing TLR2 and antagonize the effects of TLR4, domination position is evaluated between effect of TLR2 and TLR 4 in DN development. The realization of the mechanism of BPs will be coincidence with the theory of traditional Chinese medicine. This work proposed some potential suggestions for future research and the direction of the investigation. The established reseaching stage will be helpful for new drug discovery by screening from traditional Chinese medicinal materials. Exploring the Inflammatory mechanism of DN by the combination of the traditional and Western medicine, is conducive to give full taking the advantages of traditional Chinese Medicine.

评估说明

    国家自然科学基金项目“基于解毒通络探讨柴胡多糖阻断HMGB1-TLR2/4信号通路防治糖尿病肾病”发布于爱科学iikx,并永久归类于相关科学基金导航中,仅供广大科研工作者查询、学习、选题参考。国科金是根据国家发展科学技术的方针、政策和规划,以及科学技术发展方向,面向全国资助基础研究和应用研究,发挥着促进我国基础研究源头创新的作用。国科金的真正价值在于它能否为科学进步和社会发展带来积极的影响。

此文由 爱科学 编辑!:首页 > 科学基金 > 科学基金3 » 基于解毒通络探讨柴胡多糖阻断HMGB1-TLR2/4信号通路防治糖尿病肾病

推荐文章